Masaomi Tomonaga

Q: What Schools Are Affiliated With Masaomi Tomonaga

Masaomi Tomonaga is affiliated with the following schools: Nagasaki University, University of Nagasaki

Masaomi Tomonaga's AcademicInfluence.com Rankings

Masaomi Tomonaga

Philosophy

#9917

World Rank

#13545

Historical Rank

Logic

#6869

World Rank

#8426

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Masaomi Tomonaga Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Masaomi Tomonaga's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. (1994) (782)
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. (2012) (553)
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. (2007) (417)
Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. (1990) (370)
A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 (2001) (357)
Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. (2010) (338)
The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001 (2013) (306)
Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. (2002) (303)
Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. (2014) (302)
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts (2008) (276)
Array-based genomic resequencing of human leukemia (2010) (251)
Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells (1999) (246)
Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation (2001) (233)
ICSH guidelines for the standardization of bone marrow specimens and reports (2008) (209)
Retrospective nationwide survey of Japanese patients with transfusion‐dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality (2007) (200)
Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effect on normal bone marrow and leukemia cell lines. (1986) (198)
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study (2015) (195)
Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. (1995) (182)
The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes (1999) (180)
A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase. (1995) (175)
Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma (2005) (164)
High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. (1986) (159)
Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. (2005) (148)
Long-term study of indolent adult T-cell leukemia-lymphoma. (2007) (143)
Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. (1999) (132)
Fas Gene Mutation in the Progression of Adult T Cell Leukemia (1999) (130)
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. (1995) (129)
Significance of soluble interleukin‐2 receptor levels for evaluation of the progression of adult T‐cell leukemia (1994) (128)
Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. (1997) (122)
A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma (2005) (120)
Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. (1997) (114)
Possible origin of adult T‐cell leukemia/lymphoma cells from human T lymphotropic virus type‐1‐infected regulatory T cells (2005) (113)
Mutations in the mitotic check point gene, MAD1L1, in human cancers (2001) (112)
Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells (1999) (110)
Randomized study of individualized induction therapy with or without vincristine, and of maintenance—intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML‐87 study of the Japan adult leukemia study group (1993) (110)
Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. (2011) (109)
Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. (2007) (108)
Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit (2010) (107)
Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. (2001) (107)
Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature (1999) (106)
Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. (2000) (106)
Diagnostic significance of detecting pseudo‐Pelger‐Huet anomalies and micro‐megakaryocytes in myelodysplastic syndrome (1986) (105)
Human T-cell Leukemia Virus Type I Tax Protein Induces the Expression of Anti-Apoptotic Gene Bcl-xL in Human T-Cells through Nuclear Factor-κB and c-AMP Responsive Element Binding Protein Pathways (2001) (104)
Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. (1989) (102)
Aberrant expression of caspase cascade regulatory genes in adult T‐cell leukaemia: survivin is an important determinant for prognosis (2001) (101)
Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki. (2001) (99)
Features of the cytokines secreted by adult T cell leukemia (ATL) cells. (1996) (99)
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. (1996) (95)
Correlation of urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. (2000) (95)
Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. (2005) (94)
Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes (1998) (93)
Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. (2004) (91)
An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. (1996) (90)
A genomic analysis of adult T-cell leukemia (2007) (83)
Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study (JCOG9109) (2003) (81)
Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. (2001) (75)
Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir. (2006) (72)
Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials (2011) (70)
Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. (2002) (69)
The methylthioadenosine phosphorylase gene is frequently co‐deleted with the p16INK4a gene in acute type adult T‐cell leukemia (1998) (67)
Dysmegakaryocytopoiesis in acute leukaemias: its predominance in myelomonocytic (M4) leukaemia and implication for poor response to chemotherapy (1987) (63)
Efficacy of granulocyte colony‐stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study (2002) (63)
Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan. (2003) (62)
K562 cells produce and respond to human erythroid-potentiating activity. (1988) (62)
An Alternative Transcript Derived from the Trio Locus Encodes a Guanosine Nucleotide Exchange Factor with Mouse Cell-transforming Potential* (2004) (62)
Circulating interleukin‐6 levels are elevated in adult T‐cell leukaemia/lymphoma patients and correlate with adverse clinical features and survival (1998) (61)
[Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues]. (2009) (61)
Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes (2008) (61)
Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma. (2006) (60)
Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. (2003) (59)
Resveratrol Induces Downregulation in Survivin Expression and Apoptosis in HTLV-1-Infected Cell Lines: A Prospective Agent for Adult T Cell Leukemia Chemotherapy (2002) (58)
Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia (2009) (58)
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells (2004) (58)
[Intracranial hemorrhage caused by metastatic tumors]. (1985) (58)
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. (1997) (58)
Adult T‐cell leukemia cells over‐express the multidrug‐resistance‐protein (MRP) and lung‐resistance‐protein (LRP) genes (1999) (57)
Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia (1994) (56)
The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype (2003) (55)
Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells. (1998) (55)
Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. (2008) (54)
Frequency of eosinophilia in adult T‐cell leukemia/lymphoma (1992) (53)
Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. (1996) (52)
A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production. (2007) (52)
Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukaemia and juvenile chronic myeloid leukaemia: both granuloctye‐macrophage precursors and erythroid precursors carry identical marker chromosome (1986) (50)
K562 Cells Produce and Respond to Human Erythroid-Potentiating Activity (1988) (50)
Establishment of eosinophilic sublines from human promyelocytic leukemia (HL-60) cells: demonstration of multipotentiality and single-lineage commitment of HL-60 stem cells. (1986) (50)
Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. (1999) (50)
Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia. (1999) (49)
Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL). (2007) (49)
Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission (1998) (48)
Activation of cyclin D1 and D2 promoters by human T‐cell leukemia virus type I tax protein is associated with IL‐2–independent growth of T cells (2002) (48)
Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-κB pathway (2002) (47)
Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO‐1) in adult T‐cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis (1999) (47)
Matrix metalloproteinase‐9 and vascular endothelial growth factor: a possible link in adult T‐cell leukaemia cell invasion (2002) (46)
Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants. (2007) (45)
Infective dermatitis among patients with ATL in Japan (1994) (45)
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification (2007) (45)
Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21) (1997) (45)
Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody (2001) (44)
Mental health conditions among atomic bomb survivors in Nagasaki (2002) (44)
Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells. (2001) (43)
Human T-lymphotropic virus type 1 infection. (2000) (43)
Identifying progression‐associated genes in adult T‐cell leukemia/lymphoma by using oligonucleotide microarrays (2004) (43)
Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV‐1 genotype (1999) (43)
Potential immunogenicity of adult T cell leukemia cells in vivo (2005) (42)
Establishment and characterization of a new erythropoietin-dependent acute myeloid leukemia cell line, AS-E2 (1997) (40)
Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony ‐ stimulating factor: a multicenter randomized controlled study (1997) (40)
Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion. (2001) (40)
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes. (2014) (39)
Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group (2009) (39)
Tumor immunity against adult T‐cell leukemia (2005) (39)
Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias (2004) (38)
Cytochemistry of Acute Promyelocytic Leukemia (M3): Leukemic Promyelocytes Exhibit Heterogeneous Patterns in Cellular Differentiation (1985) (38)
Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group‐AML 92 study (2003) (38)
The Current Status of Therapy for Adult T-cell Leukaemia-Lymphoma in Japan (2003) (38)
Quantitative characterization and potential function of membrane Fas/APO‐1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias (1997) (38)
Sensitivity of adult T‐cell leukaemia lymphoma cells to tumour necrosis factor‐related apoptosis‐inducing ligand (2005) (38)
High rate of chromosomal abnormalities in HTLV-I-infected T-cell colonies derived from prodromal phase of adult T-cell leukemia: a study of IL-2-stimulated colony formation in methylcellulose. (1999) (37)
Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia. (1988) (37)
Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma (2006) (37)
Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL) (2002) (37)
Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome (1995) (36)
Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL) (1997) (36)
Elevated expression of CCL5/RANTES in adult T‐cell leukemia cells: Possible transactivation of the CCL5 gene by human T‐cell leukemia virus type I tax (2004) (36)
Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors. (2009) (36)
A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. (1991) (35)
Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2. (1997) (35)
A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukaemia (M1) with t(7;21) at relapse (1993) (35)
Phase I/II study of decitabine in patients with myelodysplastic syndrome: A multi‐center study in Japan (2012) (35)
Prognostic significance of the proportion of Ki‐67‐positive cells in adult t‐cell leukemia (1991) (35)
Identification of Genes Associated with the Progression of Adult T Cell Leukemia (ATL) (2000) (35)
Antibodies against p40tax Gene Product of Human T‐Lymphotropic Virus Type‐I (HTLV‐I) under Various Conditions of HTLV‐I Infection (1989) (34)
A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group. (1993) (34)
Primary central nervous system lymphomas. Immunophenotypic, virologic, and cytogenetic findings of three patients without immune defects (1994) (34)
[STUDIES ON LEUKOCYTE ALKALINE PHOSPHATASE. I. USE OF THE NAPHTHOL AS-MX PHOSPHATE-FAST BLUE RR STAINING METHOD]. (1963) (34)
Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/ Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells (2004) (34)
IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. (1991) (33)
Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR‐ABL transcript (1996) (32)
Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome. (1996) (32)
Systemic mastocytosis with extensive polypoid lesions in the intestines; successful treatment with interferon-alpha. (1998) (32)
Possible Involvement of Interferon Regulatory Factor 4 (IRF4) in a Clinical Subtype of Adult T‐Cell Leukemia (2001) (32)
Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol (2008) (31)
Soluble and membrane isoforms of Fas/CD95 in fresh adult T‐cell leukemia (ATL) cells and ATL‐cell lines (1997) (31)
Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959. (1962) (31)
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia. (2016) (30)
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas (2018) (30)
Cytogenetic and cytochemical studies on progenitor cells of primary acquired sideroblastic anemia (PASA): involvement of multipotent myeloid stem cells in PASA clone and mosaicism with normal clone. (1987) (29)
Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin's lymphoma. (1997) (29)
Human T-Cell Leukemia Virus Type I Tax Activates Transcription of the Human Monocyte Chemoattractant Protein-1 Gene through Two Nuclear Factor-κB Sites (2000) (29)
Durable remission by sobuzoxane in an hiv-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma (2004) (29)
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa (2012) (28)
Expression of the c-Met proto-oncogene and its possible involvement in liver invasion in adult T-cell leukemia. (2003) (28)
Primary adrenal lymphoma with chromosomal abnormalities. (1995) (28)
Identification of Helicobacter pylori VacA in human lung and its effects on lung cells. (2015) (27)
Microsatellite instability in adult T‐cell leukaemia (1998) (27)
Sequential karyotypic evolutions and bone marrow aplasia preceding acute myelomonocytic transformation from myelodysplastic syndrome (1984) (26)
Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry. (2000) (26)
Real-time polymerase chain reaction for quantification of HTLV-1 proviral load: application for analyzing aberrant integration of the proviral DNA in adult T-cell leukemia. (2000) (26)
Established IL‐2‐dependent double‐negative (CD4‐ CD8‐) TCRαβ/CD3+ ATL cells: induction of CD4 expression (1994) (26)
The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies (2007) (26)
Expression of myeloperoxidase enhances the chemosensitivity of leukemia cells through the generation of reactive oxygen species and the nitration of protein (2008) (26)
Morphological diagnoses of the Japan Adult Leukemia Study Group acute myeloid leukemia protocols: Central review (2001) (25)
Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies. (1996) (25)
Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes. (2009) (25)
Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells (2001) (25)
Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci (2004) (25)
Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. (2007) (25)
Prognostic Significance of CD7+CD56+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0 (2003) (25)
Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan (2008) (25)
CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia. (1989) (25)
The level of MEF but not ELF-1 correlates with FAB subtype of acute myeloid leukemia and is low in good prognosis cases. (2003) (25)
Serum levels of soluble Fas/APO-1 receptor in human retroviral infection and associated diseases. (1997) (24)
Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991. (1999) (24)
Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia. (1995) (23)
Consensus Conference on the Treatment of Aplastic Anemia. (2000) (23)
Allelotype analysis of adult T-cell leukemia. (1998) (23)
Human T-lymphotropic virus type I infection (2000) (22)
Increased levels of interleukin-6 (IL-6) in serum and spontaneous in vitro production of IL-6 by lymph node mononuclear cells of patients with angio-immunoblastic lymphadenopathy with dysproteinemia (AILD), and clinical effectiveness of cyclosporin A. (1996) (22)
Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway. (2002) (22)
Membranous nephropathy after allogeneic stem cell transplantation: meport of 2 cases (2004) (22)
Interruption of p16 gene expression in adult T‐cell leukaemia/lymphoma: clinical correlation (2003) (22)
Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes ("pre-ATL") in a 20-year follow-up study. (2005) (22)
Human T‐Lymphotropic Virus Type‐I Infection, Antibody Titers and Cause‐specific Mortality among Atomic‐bomb Survivors (1998) (21)
Atomic bomb and leukemia. (1991) (21)
Atomic bomb and leukemia. (1979) (21)
Clinical significance of serum thymidine kinase in adult T‐cell leukaemia and acute myeloid leukaemia (1995) (21)
Human Herpes virus 8-negative primary effusion lymphoma with BCL6 rearrangement in a patient with idiopathic CD4 positive T-lymphocytopenia (2008) (21)
Identification of a Novel Cytokine Response Element in the Human IFN Regulatory Factor-1 Gene Promoter1 (2000) (20)
A long term follow-up of a randomized trial comparing interferon-α with busulfan for chronic myelogenous leukemia (1998) (20)
Fas Antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-γ and tumor necrosis factor-α and potentiates apoptotic death (1999) (20)
Growth and differentiation of circulating hemopoietic stem cells with atomic bomb irradiation-induced chromosome abnormalities. (1988) (20)
Low‐dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8‐trisomy: in vitro and in vivo evidence for normal haematopoietic recovery (1985) (20)
Internal exposure to neutron-activated 56Mn dioxide powder in Wistar rats—Part 2: pathological effects (2017) (19)
Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas‐ resistant adult T‐cell leukemia cell lines (2000) (19)
New system for assessing the prognosis of refractory anemia patients (1999) (19)
Survey of Anti‐human T‐Cell Leukemia Virus Type I Antibody in Family Members of Patients with Adult T‐Cell Leukemia (1990) (19)
Vulnerable mutation Trp126 → stop of glycoprotein IX in Japanese Bernard – Soulier syndrome (1998) (19)
Remission with morphological myelodysplasia in de novo acute myeloid leukaemia: implications for early relapse (1992) (18)
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncolog (2000) (18)
Lymphoid crisis with T‐cell phenotypes in a patient with Philadelphia chromosome negative chronic myeloid leukaemia (1985) (18)
HTLV-1 Proviruses Encoding Non-Functional TAX in Adult T-Cell Leukemia (2004) (18)
Unusual morphological features of adult T-cell leukemia cells with aberrant immunophenotype. (1993) (18)
Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms. (1999) (18)
Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production. (1999) (18)
Possible association between adult T‐cell leukemia/Lymphoma and acute myeloid leukemia (1998) (17)
Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma. (2007) (17)
DNA microarray analysis of dysplastic morphology associated with acute myeloid leukemia. (2004) (17)
Risk of Adult T-cell Leukemia Developing Individuals with HTLV-I Infection (1992) (17)
Multicenter Phase II Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, In Relapsed Patients with Adult T-Cell Leukemia-Lymphoma (ATL) (2010) (17)
Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines. (2006) (17)
Reduced helper (OKT4 +): suppressor (OKT8 +) T ratios in aplastic anaemia: relation to immunosuppressive therapy (1984) (17)
Detection of preleukemic state of adult T-cell leukemia (pre-ATL) in HTLV-1 carriers. (1990) (17)
[A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)]. (1995) (16)
P53 codon 72 polymorphism is associated with disease progression in adult T‐cell leukaemia/lymphoma (2005) (16)
DNA aneuploidy of adult T-cell leukemia cells. (1994) (16)
A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin’s Lymphoma: Japan Clinical Oncology Group Study 9002 (2004) (16)
Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma. (2000) (16)
Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients (1999) (15)
Minimally differentiated acute myeloid leukemia (AML-M0) with extensive erythrophagocytosis and del(20)(q11) chromosome abnormality. (2000) (15)
Molecular detection of pre‐atl state among healthy HTLV‐1 carriers in an endemic area of Japan (1995) (15)
Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma (2007) (15)
A micromethod for chromosome preparation from individual hematopoietic colonies cultured in methylcellulose. (1985) (15)
A Randomized Trial Comparing Interferon-a! With Busulfan for Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase (2002) (15)
Randomized phase II study of mogamulizumab (KW-0761) plus VCAP-AMP-VECP (mLSG15) versus mLSG15 alone for newly diagnosed aggressive adult T-cell leukemia-lymphoma (ATL). (2013) (15)
Mutations in the Nucleolar Phosphoprotein, Nucleophosmin, Promote the Expression of the Oncogenic Transcription Factor MEF/ELF4 in Leukemia Cells and Potentiates Transformation* (2013) (14)
Helicobacter pylori infection in patients with gastric involvement by adult T‐cell leukemia/lymphoma (2002) (14)
A case of mucosa-associated lymphoid tissue lymphoma of the ampulla of Vater: successful treatment with radiation therapy. (2003) (14)
[Hypocellular acute leukemia]. (1995) (14)
Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites. (2000) (14)
Successful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome. (2002) (13)
Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes. (1995) (13)
Colony-forming unit-megakaryocyte (CFU-meg) numbers and serum thrombopoietin concentrations in thrombocytopenic disorders: an inverse correlation in myelodysplastic syndromes (2000) (13)
Homozygous Deletions of the p 15 ( MTS 2 ) and p 16 ( CDKN 2 / MTS 1 ) Genes in Adult T-cell Leukemia (2000) (12)
Leukemic blast cell colony formation in semisolid culture with erythropoietin: a case report of acute poorly differentiated erythroid leukemia. (1987) (12)
Qualitative and quantitative characterization of Fas (CD95) expression and its role in primary human acute leukemia cells. (2000) (12)
Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies (2015) (12)
Multi-clonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia (1999) (12)
Multiple γc‐receptor expression in adult T‐cell leukemia (2002) (12)
The Atomic Bombings of Hiroshima and Nagasaki: A Summary of the Human Consequences, 1945-2018, and Lessons for Homo sapiens to End the Nuclear Weapon Age (2019) (12)
Elevated plasma α-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia. (2015) (12)
Analysis of BCR/ABL abnormalities in mRNA from 20-year-old paraffin-embedded tissue for BCR/ABL rearrangement by polymerase chain reaction. (1993) (12)
Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG). (1992) (12)
Successful cord blood transplantation for mycosis fungoides (2008) (12)
Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia. (2006) (11)
The role of eosinophil morphology in distinguishing between reactive eosinophilia and eosinophilia as a feature of a myeloid neoplasm (2020) (11)
Interleukin-15 (IL-15) Can Replace the IL-2 Signal in IL-2–Dependent Adult T-Cell Leukemia (ATL) Cell Lines: Expression of IL-15 Receptor α on ATL Cells (1998) (11)
Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administration. (2003) (11)
Prognostic significance of the morphological dysplastic changes in chronic myelogenous leukemia. (1986) (11)
Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia. (1991) (11)
An autopsy case of Hermansky-Pudlak syndrome: a case report and review of the literature on treatment. (2014) (11)
Concomitant complete remission of APL and smoldering ATL following ATRA therapy in a patient with the two diseases simultaneously. (1995) (11)
Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia (1994) (11)
Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in Nagasaki prefecture, Japan (2007) (10)
Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors. (1995) (10)
Hepatic artery pseudoaneurysms in a patient treated for miliary tuberculosis. (2000) (10)
Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met. (2008) (10)
De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy. (2001) (10)
Evaluation of a Telemedicine System for Supporting Thyroid Disease Diagnosis (2001) (9)
Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts (2011) (9)
Cytochemistry of acute promyelocytic leukemia (M3): leukemic promyelocytes exhibit heterogeneous patterns in cellular differentiation. (1985) (9)
Mutational analysis of the hMSH2 gene in a wide variety of tumors. (1997) (9)
[Infectious complications in patients with adult T-cell leukemia]. (1992) (9)
Plasma M-CSF as an indicator of response to chemotherapy in adult T cell leukemia patients. (1996) (9)
Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells (2008) (9)
Clonal analysis of B-cell leukemias and lymphomas using the polymerase chain reaction for the third complementarity determining region of the IgH gene: a study of 75 cases from Nagasaki Japan. (1999) (9)
Comparative genomic hybridization analysis of Japanese B-cell chronic lymphocytic leukemia: correlation with clinical course (2006) (9)
Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group. (1999) (9)
Isochromosome 17q in a case of myelofibrosis with myeloid metaplasia terminating in blastic transformation. (1987) (9)
Clinicopathological features of acute megakaryoblastic leukaemia: Relationship between fibrosis and platelet‐derived growth factor (2013) (8)
Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies. (2015) (8)
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group. (2014) (8)
A Japanese patient with Löfgren's syndrome with an HLA-DR12 allele and review of literature on Japanese patients. (2014) (8)
Proposals for a Grading System for Diagnostic Accuracy of Myelodysplastic Syndromes (2008) (8)
[Nuclear abnormalities in Pelger-Huet anomaly; progress in blood cell morphology]. (2005) (8)
fgr proto-oncogene is expressed during terminal granulocytic differentiation of human promyelocytic HL60 cells. (1993) (8)
Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death. (1999) (8)
Morphological and immunophenotypical characterization of Japanese B-cell lymphocytic leukemia. (1994) (8)
STATISTICAL INVESTIGATION OF LEUKEMIA IN JAPAN. (1966) (8)
Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301 (2004) (8)
Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-cell Leukemia Cells (2002) (7)
The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons. (2015) (7)
Phase I Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, in Relapsed Patients (Pts) with Adult T-Cell Leukemia-Lymphoma (ATL) or Peripheral T-Cell Lymphoma (PTCL): Updated Results. (2008) (7)
Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD) (2000) (7)
[Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma]. (1999) (7)
Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma. (1994) (7)
[A randomized controlled study of rG.CSF in patients with neutropenia after induction therapy for acute myelogenous leukemia. (rG.CSF Clinical Study Group)]. (1995) (7)
Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia (2004) (6)
High expression of 67-kDa laminin receptor relates to the proliferation of leukemia cells and increases expression of GM-CSF receptor. (2011) (6)
Atomic Bomb and Leukemia : II. BIOLOGICAL EFFECTS (1991) (6)
Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-Cell Leukemia-Lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801. (2005) (6)
Proceedings of the international round table conference: FAB classification of acute leukemias correlating with response to chemotherapy. (1984) (6)
Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL) (2011) (6)
A comparative study of immunological and cytochemical profiles between adult and childhood acute lymphoblastic leukemias (ALLs): heterogeneity in adult common ALL. (1985) (6)
Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor. (2000) (6)
Late hematological effects in the atomic bomb survivors (2007) (6)
Cytogenetic studies of non-lymphocytic neoplasias using hematopoietic growth factors: GM-CSF provides pronounced mitotic increase and improvement of the quality of banded chromosomes compared to G-CSF. (1993) (6)
Rat primary T cells expressing HTLV‐I tax gene transduced by a retroviral vector: In vitro and in vivo characterization (1996) (6)
[Effectiveness of oral vitamin B12 therapy for pernicious anemia and vitamin B12 deficiency anemia]. (2002) (5)
Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 α / CCL 20 gene transcription via the NF-κ B pathway (2002) (5)
A lymphoproliferative disorder of Tγ cells with the phenotype of cytotoxic suppressor T‐cell (1985) (5)
Two Cases of Adult T-cell Leukemia/Lymphoma Involving the Terminal Ileum (2003) (5)
Constitutive Activation of NFk B in Primary Adult T-Cell Leukemia Cells (1999) (5)
Aberrant processing of Fas transcripts in adult T-cell leukemia: a possible role in tumor cell survival. (2003) (5)
Incidence and characteristics of clonal hematopoiesis in remission of acute myeloid leukemia in relation to morphological dysplasia. (1995) (5)
CFU-C abnormalities and cytochemical defects in bone marrow of adult patients during remission of acute leukemia. (1985) (5)
Methylenetetrahydrofolate reductase genotype does not play a role in adult T-cell leukemia/lymphoma pathogenesis among human T-lymphotrophic virus type 1 carriers. (2004) (5)
Autoantibodies and immunoglobulins in atomic bomb survivors with human T-lymphotropic virus type I. (1996) (5)
In vivo Retrovirus‐mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model (1997) (5)
Trial to Extract Prognostic Factors Prior to the Start of Induction Chemotherapy for Adult AML (1998) (5)
Tooth enamel ESR doses and cytogenetic doses of Nagasaki atomic-bomb survivors in comparison with DS02R1 doses (2019) (4)
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group. (1998) (4)
Superoxide production of polymorphonuclear leukocytes in patients with hematological disorders. (1983) (4)
Long-term outcome of immunosuppressive therapy for Japanese patients with lower-risk myelodysplastic syndromes (2013) (4)
No parental origin bias for the rearranged chromosomes in myeloid leukemias associated with t(9;22), t(8;21) and t(15;17). (1998) (4)
[Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia]. (1994) (4)
Fatal Cytomegalovirus Pneumonia and Associated Herpes Virus Infection in a Relapsed/Refractory Multiple Myeloma Patient Treated with Bortezomib plus Dexamethasone (2009) (4)
[A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia]. (1998) (4)
Interleukin‐15 stimulates the proliferation of peripheral blood leukemic cells from adult T‐cell leukemia patients (1998) (4)
CHROMOSOME ABERRATIONS AND NEUTROPHIL ALKALINE PHOSPHATASE IN FORTY-THREE CASES OF LEUKEMIA, INCLUDING FOURTEEN CASES OF LEUKEMIA IN ATOMIC BOMB SURVIVORS. (1967) (4)
Phase I Study of KW-0761, a Humanized Anti-CCR4 Antibody, in Patients (Pts) with Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma (ATLL) and Peripheral T-Cell Lymphoma (PTCL): Preliminary Results. (2007) (4)
Adult T-cell leukemia and opportunistic infections. (1999) (4)
[Plasmodium vivax malaria with clinical presentation mimicking acute type idiopathic thrombocytopenic purpura]. (2006) (4)
[Early resumption of activities by patients following cataract surgery]. (1972) (4)
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma (2012) (3)
The role of f-electrons at the Fermi surface of the heavy fermion superconductor β-YbAlB4 (2009) (3)
Erratum to: Internal exposure to neutron-activated 56Mn dioxide powder in Wistar rats—Part 2: pathological effects (2017) (3)
[Treatment of myelodysplastic syndrome with alfacalcidol]. (1987) (3)
Usefulness of immunocytochemistry for phenotypical analysis of acute leukemia; improved fixation procedure and comparative study with flow cytometry. (1995) (3)
Activity of Fgr protein-tyrosine kinase is reduced in neutrophils of patients with myelodysplastic syndromes and chronic myelogenous leukemia. (1996) (3)
CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan. (1996) (3)
Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors. (2014) (3)
Prophylaxis of symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with all-trans retinoic acid. (1994) (3)
Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes (2016) (3)
Expression of 67-Kda Laminin Receptor (67LR) Relates to the Aggressiveness and Poor Prognosis of AML: Modulation of the Expression of GM-CSF Receptor by 67LR. (2008) (3)
Waldenström's macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance. (2009) (3)
Spontaneous IL-8 Production by CD4(+), CD7(+) Leukemia Cells in Erythrodermic Sézary Syndrome (2002) (3)
Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex). (1991) (3)
Expression of CD8β and alteration of cell surface phenotype in adult T‐cell leukaemia cells (1997) (3)
Correlation of donor-derived keratinocytes and severity of graft-versus-host disease (GVHD) in epidermis. (2005) (3)
Retrospective Survey of Japanese Patients with Transfusion-Dependent Myelodysplastic Syndromes and Aplastic Anemia Highlights the Negative Impact of Iron Overload on Morbidity/Mortality. (2006) (3)
A clonal study of hematopoiesis using the M27 beta probe: aberrant band patterns caused by incomplete digestion of a methyl-sensitive enzyme in the the inactive X-chromosome. (1993) (3)
[Chronic myeloid leukemia]. (2001) (3)
A new translocation (4;12)(q21;q15) after combined immunosuppressive therapy in a case of hypoplastic myelodysplastic syndrome with translocation (12;15)(q23;q12) (1998) (2)
[Study on nitroblue-tetrazolium (NBT) reduction by neutrophils. I. A new histochemical method to detect NBT reduction by neutrophils (author's transl)]. (1976) (2)
del(16)(q22) in a child with acute myeloid leukemia without bone marrow eosinophilia. (1992) (2)
ATRA, NF-kappaB and ATL. (2001) (2)
Randomized Study of Intensive Individualized Induction Therapy With or Without Vincristine and of Maintenance/Intensification Therapy in Adult Acute Myeloid Leukemia (1994) (2)
Cancer Mortality in Nagasaki Atomic Bomb Survivors with Epilation (2005) (2)
Clinical significance of tissue polypeptide antigen in serum of acute nonlymphocytic leukemia. (1995) (2)
DISAPPEARANCE OF CD4 ANTIGEN IN A CASE OF ADULT T CELL LEUKAEMIA (1992) (2)
[A simple method for chromosomal preparations from individual hemopoietic colonies]. (1983) (2)
Gene Expression Profiles of CD133-positive Fractions Predict the Survival of Individuals with Acute Myeloid Leukemia. (2006) (2)
Myelodysplastic Remission in De Novo Acute Myeloid Leukemia: Implications for Early Relapse and Putative Monoclonal Remission (1994) (2)
Therapeutic angiogenesis by autologous transplantation of bone marrow mononuclear cells for peripheral artery disease (2007) (2)
[Pulmonary cryptococcosis (author's transl)]. (1982) (2)
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells (2011) (2)
[Chemotherapy and radiation therapy]. (2001) (2)
Erratum to: Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies (2016) (2)
High establishment efficiency of lymph node stromal cells which spontaneously produce multiple cytokines derived from adult T-cell leukemia/lymphoma patients. (1996) (2)
leukemia / lymphoma : correlation with clinical course Comparative genomic hybridization analysis in adult T-cell (2001) (2)
Inversion(10)(q11q24) in a case of adult T-cell leukemia. (1995) (2)
Dorsal Column Degeneration after Bortezomib Therapy in a Patient with Multiple Myeloma (2009) (2)
[Cost-effectiveness analysis of azacitidine for myelodysplastic syndromes in Japan]. (2012) (1)
[Malignant histiocytosis with leukemic picture and chromosomal abnormalities]. (1987) (1)
Assessment of the FAB classification for acute leukemias from the standpoint of light microscopic morphology. (1983) (1)
[New classification of leukemia]. (2001) (1)
[Cancer risk by radiation]. (2012) (1)
Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification. (2013) (1)
[Human lymphocyte blasttransformation in bronchial asthma and drug hypersensitivity induced by asthma allergen or specific drug]. (1971) (1)
Late Medical Effects of Atomic Bombs Still Persisting after over Sixty Years (2005) (1)
Immune pathology of myelodysplastic syndromes. (2001) (1)
[Allogeneic bone marrow transplantation for two patients with acute myeloid leukemia with trilineage myelodysplasia (T-MDS)]. (1994) (1)
Kaposi's sarcoma--associated herpesvirus-like DNA sequences are not present in adult T-cell leukemia. (1997) (1)
Hypoplastic acute myeloid leukaemia with 7 years of complete remission by low‐dose cytosine arabinoside therapy alone (1995) (1)
Incidence and Clinical Significance of PNH clone in Myelodysplastic Syndromes (2003) (1)
A New Scoring System To Predict the Prognosis of Patients with Acute Myeloid Leukemia. -Study from the Japan Adult Leukemia Study Group. (2005) (1)
Dual expression of lymphoid/basophil markers on single blast cells transformed from chronic myeloid leukemia. (1986) (1)
[Evaluation of FAB classification from cytomorphological and cytochemical view points]. (1982) (1)
[INCIDENCE OF LEUKEMIA IN ATOMIC BOMB SURVIVORS AND RELATED PROBLEMS]. (1963) (1)
Overview: effects of radiation on the human body: acute and chronic sequelae in hematopoietic organs (2012) (1)
[Radiation injury to human body: atomic bombs, Chernobyl and Fukushima]. (2011) (1)
Myelodysplastic Syndromes in Atomic Bomb Survivors in Nagasaki: A Preliminary Analysis (2005) (1)
Detection of monoclonal hematopoiesis using restriction fragment length polymorphism (RFLP) of phosphoglycerokinase (PGK) gene in a patient with hypoplastic myelodysplastic syndrome (MDS). (1993) (1)
Bronchiolitis in a patient with ulcerative colitis treated with erythromycin. (2014) (1)
[Marked dysmyelopoiesis after induction chemotherapy in a case of acute myelomonocytic leukemia (M 4) with t(6; 11)]. (1989) (1)
Alkaline phosphatase-positive leukemic monocytes in a child with acute monocytic leukemia. (1984) (1)
Minimal Residual Disease (MRD) in Adult T-Cell Leukemia/Lymphoma (ATLL) Evaluated by HTLV-1 Proviral Load and Soluble IL-2 Receptor Level in Peripheral Blood. (2005) (1)
A case of beta-thalassemia with a C----T substitution at position 654 of the second intervening sequence of the beta-globin gene. (1992) (1)
[No rearrangement of the breakpoint cluster region in two juvenile chronic myeloid leukemia]. (1991) (1)
Voices of Nagasaki after 75 Years (2021) (1)
[Chromosome 1 abnormalities at band 1p32 in two atomic bomb survivors with myelodysplastic syndrome]. (2000) (1)
Chromosome 11 rearrangement at band 11q21 in a patient with essential thrombocythemia. (1992) (1)
[Phenotypical diagnosis of Japanese chronic lymphocytic leukemia--an international cooperative study based on the French-American-British classification of mature B-cell leukemias]. (1995) (1)
[Japan Adult Leukemia Study Group (JALSG)--twelve years of activities and future direction]. (2000) (1)
[Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation]. (1989) (1)
[Histochemistry of leukemic cells]. (1969) (1)
[Nitroblue-tetrazolium reduction test]. (1978) (1)
Two Cases of Cerebral Involvement in Malignant Lymphoma (CD20+) That Responded to Combination Therapy with Rituximab and Cladribine (2012) (1)
P-7 Prognostic factors in refractory anemia according to the French-American-British classification (2005) (1)
[Difference of antibody profile for human T-lymphotropic virus type-I (HTLV-I) among individuals]. (1989) (1)
Low Dose Cytosine Arabinoside Regimen for Overt Leukemia, Hypoplastic Leukemia and Myelodysplastic Syndromes : Hypoplastic Leukemia Responds Best. (1990) (1)
Leukemia Cells T-Cell Lines and Primary Adult T-Cell T-Cell Leukemia Virus Type 1-Infected Deacetylase Inhibitor FR 901228 in Human Apoptosis Induced by the Histone (2004) (1)
[Treatment of hematologic diseases--the current status and overview: Introduction]. (1994) (0)
The seven projects and their achievements in 5 years that provide new post-COE concepts (2007) (0)
B4) Myelodysplastic syndromes and leukemias in atomic bomb survivors (1991) (0)
Correlation between Acute Radiation Injuries and Hematological Parameters in Atomic Bomb Survivors (2002) (0)
HTLV-1 carriers and paying attention to WBC count are clinically important for predicting the outcome of HTLV-1 carriers (2004) (0)
[Flow cytometric cell analysis according to CD grouping]. (1999) (0)
Acute Radiation Injuries and Hematological Parameters Measured 25 Years After the Bombing in AtomicBomb Survivors (2001) (0)
Determination of human peripheral blood mononuclear cell-mediated cytotoxicity by an agarose plate method: spontaneous release of a soluble cytotoxic factor against SRBC targets from monocytes. (1983) (0)
Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Its Malignant Progression in Radiation-Exposed Population. (2006) (0)
Nagasaki University's Center of Excellence (COE) Projects Focusing on Molecular Epidemiology of Radiation-induced Human Cancers among the Atomic Bomb Survivors and the Chernobyl/Semipalatinsk Radiation Victims (2004) (0)
[Effects of low dose Ara-C regimen in acute leukemias and RAEB]. (1989) (0)
THE OCCURRENCES OF LEUKEMIA IN THE PEOPLE EXPOSED TO THE ATOMIC BOMB EXPLOSIONS AND RELATED PROBLEMS (1963) (0)
A case of primary pulmonary T cell lymphoma (2000) (0)
Efficacy of bisphosphonate for hypercalcemia in patients with adult T-cell leukemia. (1999) (0)
[Acute myeloid leukemia expressing lymphoid associated antigens]. (1998) (0)
Geographical Study on the Frequency of Epilation among Atomic Bomb Survivors in Nagasaki (2002) (0)
Epidemiological Studies on Blood Cell Neoplasia among Atomic Bomb Survivors; Trends over 60 years and perspectives (2005) (0)
P128 Retrospective survey highlights the iron burden in Japanese transfusion-dependent patients with MDS (2007) (0)
[Discussion. Histochemical aspects of clinical pathology]. (1969) (0)
Contents, Vol. 114, Supplment 1, 1997 (1997) (0)
Immunohistochemical study of cutaneous graft-versus-host disease(GVHD) after allogeneic stem cell transplantation (2003) (0)
Relationship between Cancer Mortality and Epilation among Atomic Bomb Survivors in Nagasaki. (2001) (0)
Myeloperoxidase Increases Chemosensitivity of Leukemia Cells through the Generation of Reactive Oxigen and Nitrogen Species. (2006) (0)
[Smoldering leukemia]. (1998) (0)
Acute Mixed Leukemia (1985) (0)
Correlation between lifestyle and mortality in atomic bomb survivors (2000) (0)
Dihydroflavonol BB-1, an Extract of Natural Plant Blumea Balsamifera, Abrogates TRAIL Resistance in Adult T-Cell Leukemia/Lymphoma. (2004) (0)
significance and radiation exposure in Nagasaki atomic bomb survivors Relationship between monoclonal gammopathy of undetermined (2011) (0)
O1–066A MULTICENTER PHASE II STUDY OF MOGAMULIZUMAB (KW-0761) IN PATIENTS WITH RELAPSED PERIPHERAL OR CUTANEOUS T-CELL LYMPHOMA (2013) (0)
with refractory anemia in myelodysplastic syndromes Difference in clinical features between Japanese and German patients (2013) (0)
3 Morphologic criteria for defining granulocytic dysplasia in MDS (2011) (0)
RELATIONSHIP BETWEEN AN INCIDENCE OF M-PROTEINEMIA (1985-1995) IN ATOMIC BOMB SURVIVORS AND PAST HISTORY OF CANCER (1996) (0)
Myelodysplastic Syndrome (2005) (0)
Factor-1 Gene Promoter Element in the Human IFN Regulatory Identification of a Novel Cytokine Response (2000) (0)
Title Autocrine and / or paracrine growth of aggressive ATLL cells caused byHGF and c-Met (0)
Comprehensive Analysis of Genetic Alterations in Acute Myeloid Leukemia According to the WHO Classification. (2007) (0)
Statistical Associations between Radiation Exposure and Cardio-Respiratory : Functions in Radiology Technicians (1998) (0)
P-109 Impact of radiation exposure on the prognosis of myelodysplastic syndromes in Nagasaki atomic bomb survivors: A preliminary analysis (2013) (0)
47 Chromosomal complexity in primary myelodysplastic syndromes (MDS) in Nagasaki atomic bomb survivors (2011) (0)
A case of adult T cell leukemia complicated by monoclonal gammopathy in the course of chemotherapy. (1992) (0)
Comments to the Feature Articles (2010) (0)
Acute Erythroblastic Leukemia is a Rare, but Distinct Subtytpe of Acute Myeloid Leukemia (1998) (0)
Atomic Bomb Irradiation-induced Leukemias Revisited : Summary Data of 50 Years-Long Term Follow Up Study on Survivors (1997) (0)
A lymphoproliferative disorder of T gamma cells with the phenotype of cytotoxic/suppressor T-cell. (1985) (0)
Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis (2015) (0)
[Natural history of leukemia]. (2012) (0)
Frequent Clonal Change at Crisis From Indolent Disease Integration Patterns of HTLV-I Provirus in Relation to the Clinical Course of (1997) (0)
Definition of ringed sideroblasts (2010) (0)
SUCCESSFUL CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A CASE OF ACUTE MYELOID LEUKEMIA WITH IgA DEFICIENCY (2004) (0)
Immunophenotyping of Acute Leukemia ; Usefulness for Subclassification and Biological Characterization in FAB and WHO Classification (2004) (0)
[Therapeutic strategy for adult acute myeloid leukemia]. (2002) (0)
[Combined antibiotic therapy of infections in patients with acute leukemia]. (1988) (0)
International Consortium for Medical Care of Hibakusha and Radiation Life Science: a multidisciplinary program of Nagasaki University for the 21st Century Center of Excellence (COE) in Japan (2003) (0)
Refractory anemia with ringed sideroblasts (primary acquired sideroblastic anemia). (1988) (0)
Human T-Cell Leukemia Virus Type I Tax Activates Transcription of the Human Monocyte Chemoattractant Protein-1 Gene through Two Nuclear Factor-k B Sites (2000) (0)
A simple flow cytometric scoring system is useful for distinguishing myelodysplastic syndromes from non-clonal anemic disorders (2012) (0)
[An autopsy case of myelofibrosis with myeloid metaplasia terminating in blastic transformation with chromosomal aberration (i(17q))]. (1984) (0)
Genetic Predisposition for Monoclonal Gammopathy of Undetermined Significance–reply–II (2008) (0)
[Myelodysplastic syndrome: its features observed in clinical cases]. (2001) (0)
[Acute leukemia: chemotherapy]. (1994) (0)
[A scoring method for diagnosis of refractory anemia with excess of blasts (RAEB)]. (1982) (0)
[Ultrastructural and X-ray analytical studies on siderosomes in sideroblastic anemia (author's transl)]. (1979) (0)
C004 Proposals of division for diagnostic accuracy in myelodysplastic syndromes (2007) (0)
NEW TREATMENT STRATEGIES FOR ADULT T-CELL LEUKEMIA/LYMPHOMA (ATL) (1999) (0)
[Empiric therapy with aztreonam for febrile neutropenic patients with hematological malignancies]. (1989) (0)
P111 Analysis of modified WHO classification-based prognostic scoring system (WPSS) for Japanese MDS patients (2007) (0)
[The effects of recombinant human granulocyte colony-stimulating factor on protracted neutropenia in patients with acute myelogenous leukemia. (rG.CSF Clinical Study Group)]. (1995) (0)
[From FAB and REAL to WHO as comprehensive classification for hematopoietic and lymphoid tissues]. (2007) (0)
Statistical Associations between Radiation Exposure and Clinical Examination data -Effects of irradiation indices and starting work time- (1999) (0)
P-82 Chemokine expression in human erythroid leukemia cell line, AS-E2: Macrophage inflammatory protein-3α is induced by proinflammatory cytokines (2005) (0)
[Indication of allogeneic bone marrow transplantation (BMT) from HLA identical sibling in adult acute myeloblastic leukemia--comparative study of BMT and chemotherapy in patients with the first remission state. Nagoya BMT Group. Japan Adult Leukemia Study Group]. (1995) (0)
Epidemiological Study of Mental Health among Nagasaki A-Bomb Survivors. (1997) (0)
A Mail Survey of Mental Health Status in Atomic Bomb Survivors in Nagasaki (1999) (0)
Acute Radiation Effects of the Nagasaki Atomic Bomb by Distance and Shielding Condition of Exposure (1999) (0)
A Case of jS-thalassemia with a C->T Substitution at Position 654 the Second Sequence of the jS-globin Gene (2006) (0)
Successful treatment of nephrotic syndrome with cryofiltration in a patient with malignant lymphoma complicated with hepatitis C and mixed cryoglobulinemia (2004) (0)
Successful treatment of a chronic-phase T-315 I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon (2018) (0)
Evaluation of the distributions of cellular marrow by using magnetic resonance imaging(MRI) in patients with myelodysplastic syndromes and aplastic anemia (1994) (0)
The Genotype Consisting of Complex Karyotype and TP53 Gene Mutation Is Specific to Acute Myeloid Leukemia with Multilineage Dysplasia (2008) (0)
[Diagnosis and differential diagnosis of acute leukemia]. (2007) (0)
DNA Microarray Analysis of Stage Progression Mechanism in Adult T-Cell Leukemia. (2004) (0)
The leukemia : An advance in diagnosis and treatment.1.A fundamental for diagnosis and treatment.1.Disease type classification of leukemia.French-American-British classification. (1992) (0)
[Secondary leukemia]. (1998) (0)
[Study on nitroblue tetrazolium (NBT) reduction by neutrophils. II. Clinicopathological evaluation of NBT reduction test (author's transl)]. (1980) (0)
Leukemia, Lymphoma, and Multiple Myeloma Incidence in the LSS Cohort: 1950–2001 (2009) (0)
C006 Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification (2007) (0)
[Recent progress in hematology]. (1968) (0)
Growth of Leukemic Progenitor Cells of Acute Lymphoblastic Leukemia in Co-Culture with Murine Stromal Cell Line MS-5 (2003) (0)
Inactivation of p14 ARF in Adult T cell Leukemia/ Lymphoma (2007) (0)
Statistical Associations between Radiation Exposure and Physical Strength in Radiology Technicians (1997) (0)
O-2 Epidemiology of myelodysplasticsyndromes among Nagasaki atomic bomb survivors (2005) (0)
Loss of Endoreduplication as Morphogenesis of Micromegakaryocytes in Myelodysplastic Syndrome. (1990) (0)
[Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes]. (2012) (0)
[A patient with severe aplastic anemia responding to sequential immunosuppressive therapy]. (1985) (0)
[Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia]. (1999) (0)
Dose-response curves for cancer mortality in the Atomic bomb survivors - Possible threshold model in the dose-response (1996) (0)
Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia: The Results of a Second Multi-Center Prospective Study and the Impact of Antithymocyte Globulin on Early Relapse. (2006) (0)
[Clinical characteristics and poor outcomes in patients with de novo AML with trilineage myelodysplasia]. (1995) (0)
[Clinical usefulness of automated hematology analyzer system for WHO classification of hematological neoplasia]. (2003) (0)
The Survey of A-bomb Experience and Mental Health among A-bomb Survivors in Nagasaki (1998) (0)
[A case of cyclic neutropenia with a marked cyclic fluctuation of CFU-C concentration]. (1982) (0)
Diagnostic Validity of Combining HTLV-1 Serology and Immunophenotyping in Adult T-Cell Leukemia (1996) (0)
Mortality of A-bomb Survivors in RERF population (1996) (0)
Ishida et al-2015-British Journal of Haematology (2016) (0)
[Marinesco-Sjögren syndrome]. (1977) (0)
[Low-dose cytosine arabinoside (Ara-C) continuous infusion regimen for atypical nonlymphocytic leukemia--clinical study of the remission mechanism by serial chromosomal findings, colony formation and plasma Ara-C concentration]. (1984) (0)
[Episodic angioedema associated with eosinophilia in relapsing erythema and swelling of the right thigh]. (2003) (0)
[Correlation of immunophenotypes with chromosomal findings in acute lymphoblastic leukemia]. (1988) (0)
Epidemiology and Pathology of Atomic Bomb Irradiation-induced Leukemia (1999) (0)
1. Current Status of Cutting-edge of Medicine for Leukemia (2008) (0)
[A trial for prolongation of chronic phase of chronic myeloid leukemia--maintenance of leukocyte counts within normal range with busulfan]. (1989) (0)
[Staining of leukocyte phosphatase]. (1967) (0)
[Acute mixed leukemia--a report of three cases]. (1985) (0)
51 Analysis of prognostic factors for low risk myelodysplastic syndrome; a proposal of new scoring system (1997) (0)
[Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient]. (2003) (0)
Mortality by cause of death of A-bomb Survivors in Nagasaki based on ABS93D (1997) (0)
Serum Levels of Soluble Fas/APO-1 Receptor in HumanRetroviral Infection and Associated Diseases human retroviral infection and (2007) (0)
147 Myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria; phenotypic and molecular search for an association (1997) (0)
Impact of high-dose radiation exposure on myelodysplastic syndrome patients treated with azacitidine in Nagasaki atomic bomb survivors. (2014) (0)
Mortality of A-bomb Survivors in Nagasaki and Hiroshima (2000) (0)
Trilineage dysplasia in de novo AML: Relation to MDS (1994) (0)
Selected IL-21R Expression and Apoptosis Induction by IL-21 in Follicular Lymphoma. (2004) (0)
Carriers Leukemia / Lymphoma in Human T-lymphotropic Virus Type 1 Increased Susceptibility to Development of Adult T-Cell Polymorphism Associated with α Tumor Necrosis Factor (2001) (0)
[Enzyme histochemistry and PAS staining of blood cells for the differentiation between leukemia anlukemoid reaction and their clinical significance]. (1967) (0)
Elevated plasma a-defensins in patients with acute exacerbation of fibrotic interstitial (2015) (0)
Expression of the 67-kDa Laminin Receptor Is Associated with Increased AML Cells through the Enhanced GM-CSF/Stat5 Signaling. (2007) (0)
A New Stratification System for Adult AML That Includes FLT3-ITD as a Prognostic Factor-A JALSG Study. (2006) (0)
Granulocyte Colony-Stimulating Factor in the Therapy of Myeloid Leukemia (1992) (0)
Mortality of A-bomb Survivors in Nagasaki based on ABS93D (1995) (0)
[Progress in the field of hematology in the last 100 years: Medical history of chronic myelogenous leukemia]. (2002) (0)
O-7 Difference in clinical featuresbetween Japanese and German patients with refractory anemia according to the French-American-British classification (2005) (0)
Hypocellular AML: A clinical entity with hematological features distinct from MDS (1994) (0)
Erratum to: Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts (2012) (0)
In Vitro Study of the Independent and Combined Effects of Recombinant Human GM-CSF and G-CSF on Normal Bone Marrow Granulocytes : GM-CSF Enhances the Growth Effect but Suppresses the Terminal Maturation-inducing Effect of G-CSF (1990) (0)
Abundance of Auer Bodies and Bilobed Nuclei of Leukemic Cells may be Related to Longer Disease Free Survival of Patients with Acute Promyelocytic Leukemia (M3) (1998) (0)
Running title: WM in a stable IgG MGUS Waldenström's Macroglobulinemia in a 10-year stable IgG Monoclonal Gammopathy of Undetermined Significance (2018) (0)
A Trial of Vascular Regeneration by Autologous Bone Marrow Cells (Abstracts presented at the symposium Chernobyl 20 Years beyond) (2006) (0)
Adult T Cell Leukemia/Lymphoma (ATLL) Is a Malignant Counterpart of Regulatory T Cells (Treg). (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Masaomi Tomonaga?

Masaomi Tomonaga is affiliated with the following schools:

Masaomi Tomonaga's Academic­Influence.com Rankings

Why Is Masaomi Tomonaga Influential?

Masaomi Tomonaga's Published Works

Published Works

What Schools Are Affiliated With Masaomi Tomonaga?

Masaomi Tomonaga's AcademicInfluence.com Rankings